Dergiler / Gülhane Tıp Dergisi / 2022 / Cilt: 64 - Sayı: 2

Use of high flow nasal cannula as a modality of acute respiratory failure due to COVID-19

Sayfa
128–135
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

It is also important to clarify its contraindications and factors associated with HFNC failure.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Oxygen (O2 ) therapy is the first-line therapy for acute respiratory distress with hypoxemia due to Coronavirus disease-2019 (COVID-19).
📊
Temel Bulgular & Veri:High-flow nasal cannula (HFNC) therapy represents one of the O2 therapy alternative modalities.
💡
Sonuç & Katkı:It is also important to clarify its contraindications and factors associated with HFNC failure.
🔬Tür:Araştırma Makalesi
📍Kapsam:2019 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Oxygen (O2 ) therapy is the first-line therapy for acute respiratory distress with hypoxemia due to Coronavirus disease-2019 (COVID-19). High-flow nasal cannula (HFNC) therapy represents one of the O2 therapy alternative modalities. HFNC is a supportive O2 therapy device using a specially designed HFNC warmed and moisturizer, resulting in a stable flow rate. The physiological mechanisms of HFNC make its efficacy better than other O2 therapy applications. Management of COVID-19 focuses on preventing disease worsening, and HFNC can optimize the outcome of therapy. Further studies are necessary to evaluate the benefits of HFNC in hypoxemia management. It is also important to clarify its contraindications and factors associated with HFNC failure.

🔖

Bu Makaleye Atıf Yap

ISWANTO, I., MARFIANI, E., DEWİ, K. P., AMIN, M., DEWİ, I. P. (2022). Use of high flow nasal cannula as a modality of acute respiratory failure due to COVID-19. Gülhane Tıp Dergisi, Cilt: 64 - Sayı: 2, 128–135. https://ajindex.com/articles/526742

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. WHO. Report of the WHO - China Joint Mission on Coronavirus Disease 2019 (COVID-19). 2020. Available from: https://www. who.int/docs/default-source/coronaviruse/who-china-jointmission-on-covid-19---final-report-1100hr-28feb2020-11marupdate.pdf?sfvrsn=1a13fda0_2&download=true 2. PDPI. Pneumonia COVID-19 Diagnosis & Penatalaksanaan di Indonesia. 2020
  2. CDC. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12 March 16, 2020. Available from: https://www.cdc.gov/mmwr/ volumes/69/wr/mm6912e2.htm. 4. Roca O, Caralt B, Messika J, et al. An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy. Am J Respir Crit Care Med. 2019
  3. Wettstein RB, Shelledy DC, Peters JI. Delivered oxygen concentrations using low-flow and high-flow nasal cannulas. Respir Care. 2005
  4. Segovia B, Velasco D, Jaureguizar OA, Díaz Lobato S. Combination Therapy in Patients with Acute Respiratory Failure: High-Flow Nasal Cannula and Non-Invasive Mechanical ventilation. Arch Bronconeumol (Engl Ed). 2019
  5. Sharma S, Danckers M, Sanghavi D, Chakraborty RK. High flow nasal cannula. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2021. 8. De Jong A, Calvet L, Lemiale V, et al. The challenge of avoiding intubation in immunocompromised patients with acute respiratory failure. Expert Rev Respir Med. 2018
  6. Mauri T, Galazzi A, Binda F, et al. Impact of flow and temperature on patient comfort during respiratory support by high-flow nasal cannula. Crit Care. 2018
  7. Nishimura M. High-flow nasal cannula oxygen therapy in adults. J Intensive Care. 2015
  8. Renda T, Corrado A, Iskandar G, Pelaia G, Abdalla K, Navalesi P. High-flow nasal oxygen therapy in intensive care and anaesthesia. Br J Anaesth. 2018
  9. Zhang J, Lin L, Pan K, Zhou J, Huang X. High-flow nasal cannula therapy for adult patients. J Int Med Res. 2016
  10. Thille AW, Muller G, Gacouin A, et al. Effect of postextubation high-flow nasal oxygen with noninvasive ventilation vs highflow nasal oxygen alone on reintubation among patients at high risk of extubation failure: a randomized clinical trial. JAMA. 2019
  11. Adhikari P, Bhattarai S, Gupta A, et al. Physiological Effects of High-Flow Nasal Cannula Therapy and Its Use in Acute Cardiogenic Pulmonary Edema. Cureus. 2021
  12. e13372. 15. Parke RL, Bloch A, McGuinness SP